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Abstract 
 
Background  
Medically unexplained symptoms and signs are common in the general 
population, and can respond to appropriate managements. We aimed to quantify 
the types and prevalence of unexplained symptoms and signs experienced by 
adults with intellectual disabilities, and to determine the associated factors. 
 
Method  
In a population-based study, 1,023 adults with intellectual disabilities aged 16 
and over had a detailed health assessment which systematically considered 
symptoms and signs. Descriptive data were generated on their symptoms and 
signs. Backwards stepwise logistic modelling was undertaken to determine the 
factors independently associated with unexplained symptoms. 
 
Results  
Medically unexplained symptoms and signs were present in 664 (64.9%), 3.8 
times higher than in the general population, and 470 (45.9%) had multiple 
unexplained symptoms or signs. Some were similar to those reported in the 
general population, such as dyspnoea, dyspepsia, headache, nausea, dizziness. 
However, others are not commonly reported in the general population, including 
dysphagia, ataxia, polyuria, oedema, skin rash. Having unexplained symptoms 
and signs was independently associated with older age, female gender, not 
having Down syndrome, extent of intellectual disabilities, and more GP visits in 
the last 12 months. It was not associated with living in deprived areas, type of 
living/support arrangements, number of hospital visit in the last 12 months, 
smoking, autism, problem behaviours, or mental disorders. 
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Conclusions  
People with intellectual disabilities have substantial additional unexplained 
symptoms and signs, some of which are painful or disabling. These findings 
should inform the content of health checks undertaken for adults with intellectual 
disabilities, which should not just focus on management of their long term 
conditions and health promotion.   
 
Keywords  
 
Intellectual disabilities, medically unexplained symptoms and signs, health, health 
checks 
 
Introduction 
 
People with intellectual disabilities face significant health inequalities. They have a 
high prevalence of health problems and a shorter life expectancy than the general 
population (NHS Health Scotland, 2004; Emerson & Baines, 2010). Not only are 
their levels of health needs higher than the general population, their patterns of 
health needs are different and their health needs are often unmet (Cooper et al. 
2004; Baxter et al. 2006; Emerson & Baines, 2010; Cooper et al. 2014). They are 
known to experience specific disorders at a higher rate than the general 
population, such as epilepsy, psychosis, gastro-oesophageal reflux disorder, 
constipation, sensory impairments (Cooper et al. 2015), but less is known about 
the symptoms and signs they experience that have no identified medical cause.  
 
Medically unexplained symptoms are a relatively common presentation of the 
general population in primary health care settings, comprising between 15-19% 
of consultations (Mumford et al. 1991; Peveler et al. 1997). Examples include 
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abdominal pain, backache, headache, pelvic pain, functional bowel symptoms, 
dizziness and fatigue. Although thorough medical investigation of such symptoms 
results in a high proportion remaining unexplained, there are management 
approaches which can be helpful, including acknowledgement of the problem, 
reassurance, identification of stressors, antidepressants, and psychological 
approaches (Burton, 2003; Schweitzer, 2006). Hence, identification and then 
intervention for these disorders is important to reduce suffering. Whether 
medically unexplained symptoms have the same presentations, and are as 
common, in people with intellectual disabilities is unknown. 
 
Although health checks for the general population have been shown to be 
ineffective (Krogsbøll et al. 2010), three randomised control trials from Australia 
and Scotland have demonstrated that health checks may be useful for people 
with intellectual disabilities who are a high risk population for unmet needs 
(Lennox et al. 2007; Lennox et al. 2010; Cooper et al. 2014). However it is 
unclear what these health checks should include for maximum benefit, 
particularly with regards to symptoms and signs. In England, health checks for 
people with intellectual disabilities are funded as part of the services that general 
practitioners can opt into providing for their registered patients; but the content 
of these health checks is not prescribed. A study of these health checks has found 
that they tend to focus on management of long term conditions, on which there 
has also been considerable recent emphasis in the general practitioner contract 
(Chauhan et al. 2010). This has benefits as it is likely to be associated with longer 
term health gains, but also brings a potential disadvantage, as this part of the 
general practitioner contract (the Quality and Outcomes Framework) is an 
approach directed by evidence on the needs of the general population, rather 
than those that might be particularly pertinent for people with intellectual 
disabilities.  
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This study aims to describe the prevalence of unexplained symptoms and signs 
experienced by people with intellectual disabilities, through a large-scale, 
population based study, and to identify the factors independently associated with 
them. This will help to inform the development of health check materials to 
include the common symptoms and signs amongst people with intellectual 
disabilities (in addition to the current approach of management of common long-
term health conditions). 
 
Methods 
 
Adults with intellectual disabilities were recruited to the study from part of the 
Greater Glasgow Health Board area, Scotland. They were aged 16 and over, and 
identified through an extensive process via primary healthcare services, the 
Health Board, local specialist intellectual disabilities health services, social work 
services for people with intellectual disabilities, day services, and local authority 
funding arrangements for persons receiving paid support of any kind. All of 
Greater Glasgow’s 631 general practitioners were paid a fee for each person 
registered with them who they identified for the project. Methods are described in 
greater detail elsewhere (Cooper et al. 2007). Individual consent to participate 
was taken from each participant. For participants who lacked capacity to consent, 
consent was taken from the nearest carer, in keeping with Scottish law.  
 
Each participant was assessed by a registered nurse and a general practitioner. 
The team of six registered nurses had specialist qualifications in working with 
adults with intellectual disabilities and were trained in the use of the assessment 
instruments. The three general practitioners had a special interest in working with 
adults with intellectual disabilities. Each participant’s primary health care case 
notes were reviewed using a semi-structured format, prior to a detailed face to 
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face assessment. The face to face assessment was conducted with support from 
the person’s paid or family carer. The assessment was conducted using the C21st 
Health Check, which was designed specifically for use with adults with intellectual 
disabilities, and provides a comprehensive list of symptoms and signs that are 
systematically enquired about and examined for. A purpose-designed 
demographic form was used to collect information on demographic factors. Level 
of intellectual disabilities was determined by scores on the Vineland Scale (Survey 
Form) (Sparrow et al. 1984), and the C21st Health Check. The assessment 
process took about 4 hours per participant. 
 
Two academic physicians (a general practitioner and an intellectual disabilities 
psychiatrist) jointly reviewed the symptoms and signs known prior to the 
assessment and discovered through it, against participants’ elicited medical 
diagnoses, and classified them as either explained or unexplained. They followed 
the symptom list included in the International Statistical Classification of 
Diseases, 10th Revision (World Health Organisation, 1992), chapter XVIII 
(symptoms, signs and abnormal clinical and laboratory findings, not elsewhere 
classified). The analysis was conducted using SPSS 22.0. Descriptive data were 
obtained for the prevalence of symptoms and signs. Associations were 
investigated using binary logistic regression. The backwards stepwise model was 
used, with the covariate with the least impact on the outcome variable being 
removed at each step. Associations were investigated between the dependent 
variable of presence of unexplained symptoms and signs, and the independent 
variables of age, gender, level of ability, smoking status, autism spectrum 
disorders, problem behaviours, mental ill health of any type (excluding autism 
spectrum disorders, problem behaviours and specific phobias), type of 
living/support arrangement, Down syndrome, and area based measure of 
deprivation of person’s residence. 
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Results 
 
Assessments were completed for 70.6% of the eligible population. Of these, valid 
consent was recorded for 92.7%. This resulted in a sample of 1,023 adults. 562 
(54.9%) were men, and 461 (45.1%) were women, with a mean age of 43.9 
(range 16-83). 398 people (38.9%) had mild intellectual disabilities, 248 had 
moderate (24.2%), 193 (18.9%) had severe, and 184(18.0%) profound 
intellectual disabilities. The cause of intellectual disabilities was Down syndrome 
for 186 people (18.2%). 390 (38.1%) people lived with a family carer, 467 
(45.7%) with paid carer support, 102 (10.0%) lived independently without a 
carer, and 64 (6.3%) lived in a congregate care setting.  
 
A total of 1,734 individual symptoms and signs were present. 769 (44.3%) of 
these symptoms and signs were known about and had been presented to the GP 
prior to the assessment. Of these 1,734 symptoms, 1,386 (79.9%) were 
medically unexplained and 348 (20.0%) were explained. 
 
The overall prevalence of symptoms and signs (explained and unexplained) was 
71.5% (731 people); 664 (64.9%) had at least one medically unexplained 
symptom or sign, and 263 (25.7%) had at least one explained symptom or sign. 
Table 1 reports the types of symptoms and signs experienced, and their 
prevalence. It displays the prevalence of unexplained and explained symptoms 
and signs individually, with the final column representing the overall prevalence 
of the symptom or sign (the sum of the previous two columns). The most 
prevalent unexplained symptoms and signs were ataxic gait/gait disorders 
(16.9%), dysphagia (12.3%), oedema (11.2%), and skin rash/swelling (10.0%).  
 
- insert table 1 about here – 
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Table 2 reports the frequency (percentage) of the number of symptoms and signs 
experienced. It displays the frequency (percentage) of people with each number 
of unexplained symptoms/signs (Column 2) and explained symptoms/signs 
(column 3). In column 4, it displays the frequency (percentage) of people with 
each total number of unexplained or explained symptoms and signs. For example, 
a person could have 11 total unexplained or explained symptoms in column 4 if 
they had 5 unexplained symptoms/signs and 6 explained symptoms/signs, or if 
they had 8 unexplained symptoms/signs and 3 unexplained symptoms/signs; to 
have no total unexplained or explained symptoms/signs, they would have to have 
zero unexplained and zero explained symptoms/signs. (Column 4 is therefore not 
a sum of the preceding two columns.) 470 (45.9%) of people experienced 
multiple (2 or more) unexplained symptoms and signs. 
 
- insert table 2 about here – 
 
Table 3 presents the factors independently associated with the presence of 
unexplained symptoms and signs. 14 participants (1.4%) had missing data and 
were excluded from the analysis. The presence of unexplained symptoms and 
signs was independently associated with: older ages but not after age 75 years, 
female gender, not having Down syndrome, a higher number of general 
practitioner visits in the last 12 months, and having profound intellectual 
disabilities. It was not associated with living in areas of neighbourhood 
deprivation, type of living/support arrangements, smoking status, autism 
spectrum disorders, problem behaviours, mental disorders, or number of hospital 
visits in the last 12 months. 
 
 - insert table 3 about here – 
 
 
 Medically unexplained symptoms and signs 
9 
 
Discussion 
 
In this study, the prevalence of medically unexplained symptoms and signs in 
adults with intellectual disabilities was 64.9%, and 45.9% had multiple 
unexplained symptoms or signs, which is much higher than that encountered in 
the general population. Hence, in addition to having a high prevalence of 
diagnosed health problems, the majority of adults with intellectual disabilities 
experience symptoms and signs that are medically unexplained. A number of 
these are painful and/or disabling, and drawing on findings about medically 
unexplained symptoms in the general population, many might be improved if 
properly managed (Burton, 2003; Schweitzer, 2006). Despite the very high 
prevalence, this is surprisingly an area of health need that has not previously 
attracted attention for adults with intellectual disabilities.  
 
This level of medically unexplained symptoms and signs is 3.8 times higher than 
that reported in the general population (Mumford et al. 1991; Peveler et al. 
1997). The assessment uncovered symptoms and signs that had not been 
previously attended to by the persons GP, even though the individuals with 
medically unexplained symptoms and signs were more frequent attenders to their 
GPs than those without such symptoms. Prior to the assessment, the rate of 
medically unexplained symptoms and signs known to the GPs was 1.7 times 
higher than that seen in for the general population.  
 
Some of the unexplained symptoms and signs we found are similar to those 
commonly reported in the general population, such as dyspnoea, dyspepsia, 
headache, nausea, dizziness (Mumford et al. 1991; Peveler et al. 1997). 
However, others are not commonly recognised in the general population, 
including dysphagia, ataxia, polyuria, oedema, skin rash. This might suggest a 
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lower level of medical care for the adults with intellectual disabilities with regards 
to these conditions, or alternatively reflects differences in their patterns of 
presentation. In either case, it highlights that the role of health checks should not 
be just in the management of long term conditions and health promotion, but in 
actively reviewing symptoms and signs, offering further investigation where 
indicated, and providing supportive management for medically unexplained 
symptoms. Our findings also offer some guidance to the types of symptoms and 
signs that should routinely be incorporated into enquiries and examinations 
conducted in health checks for adults with intellectual disabilities. 
 
In keeping with findings in the general population, females and frequent general 
practice attenders were more likely to have unexplained symptoms and signs. 
Contrary to the general population, older rather than younger, people were more 
likely to have these symptoms, but not over the age of 75 years (although there 
were only 16 adults with intellectual disabilities in this oldest age category). 
There was a gradient in odds ratio across the levels of intellectual disabilities, 
though this was only statistically significant at the level of profound intellectual 
disabilities. The complexity of health needs of people with profound intellectual 
disabilities might contribute to them having higher levels of unexplained 
symptoms and signs than adults at other levels of intellectual disabilities.  The 
association between not having Down syndrome and unexplained 
symptoms/signs may be due to the lower overall levels of mental health problems 
in Down syndrome (Mantry et al. 2008), and a higher awareness of health 
professionals and carers of the physical complications of Down syndrome.   
 
Strengths of the study are the systematic, comprehensive, and detailed 
assessment of health symptoms and health conditions, the comprehensive case 
ascertainment, large sample size, and high participation rate. A limitation of the 
study is the low R-squared value (17.4%) of the regression model. This indicates 
 Medically unexplained symptoms and signs 
11 
 
that the model does not explain a great deal of the variability in the presence of 
unexplained signs and symptoms. 
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Table 1 – Prevalence (%) of types of symptoms and signs 
 
Symptom 
 
Unexplained 
(n=1,023) 
Explained 
(n=1,023) 
Total 
(n=1,023) 
Dyspnoea/wheezing 89 (8.7%) 42 (4.1%) 131 (12.8%) 
Chest pain 39 (3.8%) 0  39 (3.8%) 
Purulent sputum 1 (0.1%) 2 (0.2%) 3 (0.3%) 
Haemoptysis 2 (0.2%) 0 2 (0.2%) 
Nausea and vomiting 46 (4.5%) 21 (2.1%) 67 (6.6%) 
Abdominal pain 38 (3.7%) 41 (4.0%) 79 (7.7%) 
Dyspepsia 83 (8.1%) 14 (1.4%) 97 (9.5%) 
Dysphagia 126 (12.3%) 21 (2.1%) 147 (14.4%) 
Abdominal mass 3 (0.3%) 3 (0.3%) 6 (0.6%) 
Jaundice 2 (0.20%) 0 2 (0.2%) 
Change in bowel habit 1 (0.10%) 1 (0.1%) 2 (0.2%) 
Neurological symptoms 22 (2.2%) 5 (0.5%) 27 (2.6%) 
Headache 74 (7.2%) 3 (0.3%) 77 (7.5%) 
Involuntary tremor and 
movement disorders 
59 (5.8%) 13 (1.3%) 72 (7.0%) 
Ataxic gait/gait disorders 173 (16.9%) 133 (13.0%) 306 (29.9%) 
Disorders of micturition 34 (3.3%) 1 (0.10%) 35 (3.4%) 
Haematuria 41 (4.0%) 0 41 (4.0%) 
Polyuria 87 (8.5%) 0  87 (8.5%) 
Other disorders of micturition 
(excluding incontinence) 
32 (3.1%) 4 (0.4%) 36 (3.5%) 
Dizziness/syncope 42 (4.1%) 1 (0.1%) 43 (4.20%) 
Rhythm disorder 1 (0.1%) 1 (0.1%) 2 (0.2%) 
Blood pressure 82 (8.0%) 1 (0.1%) 83 (8.1%) 
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Cyanosis 1 (0.1%) 0  1 (0.1%) 
Oedema 115 (11.2%) 2 (0.2%) 117 (11.4%) 
Anorexia 60 (5.9%) 19 (1.9%) 79 (7.7%) 
Malaise and fatigue 18 (1.8%) 2 (0.2%) 20 (2.0%) 
Skin Rash/swelling 103 (10.0%) 13 (1.2%) 116 (11.3%) 
Other  4 (0.4%) 0  4 (0.4%) 
Other pain 8 (0.8%) 5 (0.5%) 13 (0.8%) 
Any symptom or sign 664 (64.9%) 263 (25.7%) 731 (71.5%) 
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Table 2 – Prevalence  (%) of number of symptoms and signs 
 
Number of symptoms and 
signs 
 
Unexplained 
(n=1,023) 
Explained 
(n=1,023) 
Unexplained 
or Explained 
(n=1,023) 
0 359 (35.1%) 760 (74.3%) 292 (28.5%) 
1 294 (28.7%) 200 (19.6%) 256 (25.0%) 
2 176 (17.2%) 44 (4.3%) 208 (20.3%) 
3 108 (10.6%) 18 (1.8%) 135 (13.2%) 
4 45 (4.4%) 0 66 (6.5%) 
5 24 (2.3%) 0 36 (3.5%) 
6 9 (0.9%) 1(0.1%) 16 (1.6%) 
7 3 (0.3%) 0 7 (0.7%) 
8 4 (0.4%) 0 1 (0.1%) 
9 1 (0.1%) 0 2 (0.2%) 
10 0 0 2 (0.2%) 
11 0 0 2 (0.2%) 
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Table 3 – Factors independently associated with the presence of 
unexplained symptoms and signs 
 
Variable Odds ratio (95% CI)         β          P 
Age  
   16-24 
  
Reference 
   
   25-34 1.689 (1.030-2.770) .524 .038 
   35-44 1.488 (0.948-2.336) .398 .084 
   45-54 2.432  (1.521-3.889) .889 .000 
   55-64 2.135  (1.298-3.510) .758 .003 
   65 -74 3.569 (1.765-7.217) 1.272 .000 
    75+ 2.894 (0.760-11.026) 1.063 .119 
Gender 
   Male 
 
Reference 
   
   Female 1.687 (1.280 – 2.223) 0.523 .000 
Level of intellectual 
disabilities 
  Mild 
 
 
Reference 
   
  Moderate 1.261 (0.894-1.779) .232 .187 
  Severe 1.422 (0.971-2.082) .352 .071 
  Profound  1.551 (1.049-2.295) .439 .028 
Down syndrome .643 (0.457-0.904) -0.442 .011 
GP visits in last 12 
months 
1.054 (1.022-1.086) .052 .001 
R squared = 17.4% 
(-2Log Likelihood (original)/Model Chi squared = 1225.853/70.607=17.4%) 
 
 
